Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 26, 2010Arthritis & Rheumatism

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4‐related systemic disease

View Full Paper
Ask AI
Bookmark
Share

Authors

AKArezou KhosroshahiEmory UniversityDBDonald B. BlochMassachusetts General Hospital
Vikram Deshpande
Vikram DeshpandeBoston University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Khosroshahi et al. (2010) studied this question.

synapsesocial.com/papers/6a71e702a7fbea1e440888d8https://doi.org/10.1002/art.27435
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IgE Versus IgG4 Production Can Be Differentially Regulated by IL-101998 · 586 citations
  2. 2The Subclass Nature and Clinical Significance of the IgG Antibody Response in Patients Undergoing Allergen‐Specific Immunotherapy1985 · 212 citations
  3. 3Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus2004 · 461 citations
  4. 4Autoimmune Pancreatitis: Clinical and Radiological Features and Objective Response to Steroid Therapy in a UK Series2007 · 165 citations